Rainbow Childrens Medicare Limited — PPTs, 09-02-2025: Investor Presentation

**Financial Highlights**: For Q3 FY25, Rainbow Children’s Medicare reported revenue from operations of ₹3,981 Cr, a significant increase of 18% YoY from ₹3,360 Cr. EBITDA also saw growth, reaching ₹1,344 Cr, marking a 13.8% rise. The company's profit after tax (PAT) stood at ₹689 Cr, up 10.2% from the previous year.

**Strategic Initiatives and Growth Drivers**: The company continues to expand its operations, with plans for new hospitals in major cities, enhancing its pediatric healthcare facilities. The revenue increase demonstrates effective execution of their growth strategy.

**Business Developments**: The ongoing expansion includes commissioning new beds across various states, including significant upcoming facilities in Coimbatore and Gurugram.

**Market Position and Competitive Advantage**: Rainbow maintains a robust market position, being India’s largest pediatric hospital chain with a strong emphasis on quality care and notable accreditations. Their innovative hub-and-spoke model enhances access to specialized services across regions.

**Investor Implications**: With steady revenue growth and strategic expansions, investors should observe the company's performance trends closely, as these moves could lead to further market share gains and enhance long-term profitability. Positive outlook for sustained growth appears evident.